Market Research Logo

Signal Genetics, Inc. (SGNL) - Product Pipeline Analysis, 2016 Update

Summary

Signal Genetics, Inc. (Signal Genetics) is a molecular diagnostic company that offers diagnostic services. The company's Myeloma Prognostic Risk Signature test is a microarray-based gene expression profiling assay used to assist the management of patients with multiple myeloma and related disorders. It offers biopharma services such as Signal Genetics collaborative research capabilities, specimen processing, gene expression profiling, online result reporting, and regulatory and data management expertise. Signal Genetics provides the MyPRS test, CLIA-certified reference laboratory located in Little Rock, Arizona. The company's research laboratory performs cell-sorting, isolation and gene expression profiling services for pharmaceutical and research organizations. Signal Genetics is headquartered in Carlsbad, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Signal Genetics, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Signal Genetics, Inc. Company Snapshot
Signal Genetics, Inc. Company Overview
Signal Genetics, Inc. Pipeline Products and Clinical Trials Overview
Signal Genetics, Inc. – Pipeline Analysis Overview
Key Facts
Signal Genetics, Inc. - Major Products and Services
Signal Genetics, Inc. Pipeline Products by Development Stage
Signal Genetics, Inc. Pipeline Products Overview
BreastGeneDX
BreastGeneDX Product Overview
ColonGeneDX
ColonGeneDX Product Overview
LungGeneDX
LungGeneDX Product Overview
Signal Genetics, Inc. - Key Competitors
Signal Genetics, Inc. - Key Employees
Signal Genetics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Signal Genetics, Inc., Recent Developments
May 26, 2016: Signal Genetics Receives Extension to Comply with Nasdaq Continued Listing Requirement
May 16, 2016: Signal Genetics Highlights Recent Achievements And Reports First Quarter 2016 Financial Results
Mar 16, 2016: Signal Genetics Highlights Recent Achievements and Reports Fourth Quarter and Full-Year 2015 Financial Results
Nov 12, 2015: Signal Genetics Highlights Recent Achievements and Reports Third Quarter 2015 Financial Results
Nov 05, 2015: Signal Genetics' MyPRS Highlighted in the Journal Leukemia
Oct 20, 2015: Signal Genetics Expands Reimbursement of MyPRS With Additional Preferred Provider Organization Agreements
Sep 24, 2015: Signal Genetics Granted First European Patent for MyPRS
Sep 17, 2015: Signal Genetics Appoints Richard Bender, MD, FACP as Chief Medical Officer
Sep 08, 2015: Signal Genetics and Moffitt Cancer Center Enter Into Sponsored Research Agreement in Multiple Myeloma
Aug 12, 2015: Signal Genetics Highlights Recent Achievements and Reports Second Quarter 2015 Financial Results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Signal Genetics, Inc. Pipeline Products and Clinical Trials Overview
Signal Genetics, Inc. Pipeline Products by Equipment Type
Signal Genetics, Inc. Pipeline Products by Indication
Signal Genetics, Inc., Key Facts
Signal Genetics, Inc., Major Products and Services
Signal Genetics, Inc. Number of Pipeline Products by Development Stage
Signal Genetics, Inc. Pipeline Products Summary by Development Stage
BreastGeneDX - Product Status
BreastGeneDX - Product Description
ColonGeneDX - Product Status
ColonGeneDX - Product Description
LungGeneDX - Product Status
LungGeneDX - Product Description
Signal Genetics, Inc., Key Employees
Signal Genetics, Inc., Other Locations
List of Figures
Signal Genetics, Inc. Pipeline Products by Equipment Type
Signal Genetics, Inc. Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report